A post hoc analysis evaluates zanubrutinib vs acalabrutinib-venetoclax in treatment naive chronic lymphocytic leukemia using indirect comparisons of data from two phase 3 trials.

The trial, of nearly 20,000 patients in one health insurance plan, found that those given free access to the app were no more ...

A nightmare ER shift — and a little anger — led this doctor into a world of decision science, triage heuristics, and building ...

New UK clinical trial rules come into force today, cutting set-up times by more than a quarter and making trial registration ...

The Obesity Medicine Association’s interactive tool was designed to help clinicians practice real-world obesity-care ...

A new study explores whether first-time seizures are associated with a higher risk for cancer in the short or long term.

Medical specialties in which most doctors think they have either a promising or grim near-term (next 3 years) future are ...

Monica Lypson, MD, keeps a white coat hanging on the back of her office door, just in case she needs it. As a professor of ...

Patients who undergo stepwise escalation often reach treatment failure more often.” He noted that combination therapy may be ...

Latency beyond 12 hours after term prelabour rupture of membranes is independently linked to a higher likelihood of maternal ...

Urgent surgery and preoperative haemodynamic instability strongly predict in-hospital death in native aortic valve ...

Women with acromegaly experience a significantly higher disease burden and poorer physical and mental quality of life than ...